Arnnon Geshuri Sells 7,500 Shares of Teladoc Health, Inc. (NYSE:TDOC) Stock

Teladoc Health, Inc. (NYSE:TDOC) insider Arnnon Geshuri sold 7,500 shares of the business’s stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $15.06, for a total value of $112,950.00. Following the completion of the transaction, the insider now directly owns 38,470 shares of the company’s stock, valued at approximately $579,358.20. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Teladoc Health Stock Performance

NYSE TDOC opened at $15.10 on Friday. Teladoc Health, Inc. has a twelve month low of $14.29 and a twelve month high of $30.41. The company has a quick ratio of 3.47, a current ratio of 3.54 and a debt-to-equity ratio of 0.66. The business has a 50-day moving average price of $17.51 and a 200-day moving average price of $18.58.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Tuesday, February 20th. The health services provider reported ($0.17) EPS for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.05. Teladoc Health had a negative return on equity of 9.22% and a negative net margin of 8.47%. The firm had revenue of $660.50 million during the quarter, compared to the consensus estimate of $670.79 million. During the same period in the prior year, the company earned ($0.23) EPS. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. Equities analysts predict that Teladoc Health, Inc. will post -1.07 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Cantor Fitzgerald initiated coverage on shares of Teladoc Health in a report on Thursday, February 29th. They set an “overweight” rating and a $22.00 price objective for the company. Canaccord Genuity Group lowered their price target on Teladoc Health from $34.00 to $28.00 and set a “buy” rating on the stock in a report on Wednesday, February 21st. Truist Financial reduced their price objective on Teladoc Health from $23.00 to $17.00 and set a “hold” rating for the company in a research report on Wednesday, March 6th. Royal Bank of Canada dropped their target price on Teladoc Health from $30.00 to $25.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 21st. Finally, Barclays reduced their price target on shares of Teladoc Health from $26.00 to $25.00 and set an “overweight” rating for the company in a research report on Wednesday, February 21st. Eight research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $22.43.

Hedge Funds Weigh In On Teladoc Health

A number of large investors have recently made changes to their positions in TDOC. ARK Investment Management LLC boosted its position in shares of Teladoc Health by 4.5% during the fourth quarter. ARK Investment Management LLC now owns 21,224,565 shares of the health services provider’s stock valued at $457,389,000 after buying an additional 912,692 shares during the period. Vanguard Group Inc. grew its position in Teladoc Health by 11.8% in the 4th quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock valued at $377,451,000 after acquiring an additional 1,855,480 shares during the last quarter. Renaissance Technologies LLC increased its stake in Teladoc Health by 30.8% in the second quarter. Renaissance Technologies LLC now owns 4,407,819 shares of the health services provider’s stock worth $111,606,000 after purchasing an additional 1,038,319 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of Teladoc Health by 25.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider’s stock worth $82,636,000 after purchasing an additional 767,999 shares during the last quarter. Finally, Two Sigma Investments LP boosted its stake in shares of Teladoc Health by 68.6% during the first quarter. Two Sigma Investments LP now owns 3,191,291 shares of the health services provider’s stock valued at $82,654,000 after purchasing an additional 1,298,934 shares during the period. 76.82% of the stock is owned by hedge funds and other institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.